WallStreetZenWallStreetZen

NASDAQ: CVKD
Cadrenal Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Cadrenal Therapeutics earnings were -$10.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CVKD earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$4.2M, up 73.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CVKD reported annual earnings of -$10.7M, with 27.5% growth.

CVKD earnings history

Current Revenue
$0.0
Current Earnings
-$10.7M
Current Profit Margin
0%

CVKD Return on Equity

Current Company
-202.5%
Current Industry
-2%
Current Market
34.1%
CVKD's Return on Equity (-202.5%)... subscribe to Premium to read more.
High Return on Equity Performance

CVKD undefined

Current Company
-156%
Current Industry
-0.4%
CVKD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CVKD announces earnings.

CVKD undefined

Current Company
-143.17%
Current Industry
5.9%

CVKD vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CVKD-$10.65M-$10.65MN/A-$8.73
PLUR-$20.42M-$19.86MN/A-$3.69
KZR-$81.10M-$83.74MN/A-$11.49
ALXO-$132.25M-$134.85MN/A-$2.58
ESLA-$8.85M-$8.85MN/A-$0.26
View Top Biotech Stocks

Cadrenal Therapeutics Earnings Reports & History FAQ

What were Cadrenal Therapeutics's earnings last quarter?

Cadrenal Therapeutics (NASDAQ: CVKD) reported Q4 2024 earnings per share (EPS) of -$2.74, up 275.34% year over year. Total CVKD earnings for the quarter were -$4.19 million. In the same quarter last year, Cadrenal Therapeutics's earnings per share (EPS) was -$0.73.

If you're new to stock investing, here's how to buy Cadrenal Therapeutics stock.

Is Cadrenal Therapeutics profitable or losing money?

As of the last Cadrenal Therapeutics earnings report, Cadrenal Therapeutics is currently losing money. Cadrenal Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$10.65 million, a 27.45% increase year over year.

What was CVKD's earnings growth in the past year?

As of Cadrenal Therapeutics's earnings date in Q2 2025, Cadrenal Therapeutics's earnings has grown year over year. CVKD earnings in the past year totalled -$10.65 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.